Thomas Martin, MD
Associate Editor
Dr. Martin is Clinical Research Director of Hematologic Malignancies at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center.
Articles by Thomas Martin, MD
Thomas G. Martin, MD, and Saad Z. Usmani, MD, MBA, FACP, debate CAR-T vs bispecific antibodies for R/R MM.
As 2022 came to a close, the Blood Cancers Today Editorial Board shared their highlights from the year.
Thomas Martin, MD, discusses advances in frontline treatments for multiple myeloma, the need for novel agents, and more.
We are entering the great era of immunotherapy in multiple myeloma, as we’ve had significant...
670 Madison Ave.
Manalapan, NJ 07726